Chemfab Alkalis Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2025.
CHEMFAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemfab Alkalis' board approved audited financial results for Q4 and FY25 with an unmodified opinion from statutory auditor Deloitte Haskins & Sells LLP. On a standalone basis, FY25 revenue from operations fell slightly to Rs. 32,209 lakhs (vs Rs. 32,729 lakhs in FY24), while net profit dropped sharply to Rs. 1,524 lakhs from Rs. 2,999 lakhs — a decline of about 49%. Consolidated results swung to a net loss of Rs. 694 lakhs (vs profit of Rs. 2,632 lakhs) due to a Rs. 989 lakh exceptional write-off at subsidiary Chemfab Alkalis Karaikal (CAKL) on its Caustic Soda Plant project. The board recommended a final dividend of Rs. 1.25 per share (12.5%) subject to shareholder approval. New internal auditors (Brahmayya & Co) and a 5-year appointment for secretarial auditors (M. Damodaran & Associates LLP) were also approved. The company plans to sell 667.49 acres of land at its Salt Division 2 in FY26.
Sharp standalone profit decline and a consolidated loss due to the subsidiary write-off are negative signals, though the small dividend and asset sale plans could provide some support. Investors should watch for execution on the planned land sale and any further updates on the troubled CAKL Caustic Soda project.